Brought to you by 
Enterome gets €10mm so far in Series B
01 May 2014
Executive Summary
Enterome Bioscience SA (creating drugs and diagnostics for microbiome-related diseases) raised €10mm ($13.8mm) in the first tranche of its Series B financing to returning shareholders Seventure, Lundbeckfond Ventures, and Omnes Capital. Funds will support continued development of its Metagenotyping process used in biomarker discovery and patient stratification in conditions such as metabolic and inflammatory bowel diseases.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Enterome gets €10mm so far in Series B
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice